MedPath
NMPA Approval

Spironolactone Tablets

国药准字H20247220

September 20, 2024

国药准字H32020050

Drug Information

螺内酯片

片剂

100mg

化学药品

September 20, 2024

Company Information

Applicant Company

太仓港港口开发区石化区协鑫西路12号

Manufacturing Company

江苏太仓港港口开发区石化区协鑫西路12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

螺内酯片 - NMPA 批准文号 | MedPath